Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-05-29FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a fixed-dose combination of amlodipine besylate and atorvastatin calcium (amlodipine and atorvas…
-
CLINICAL_TRIALS trial_result · 2008-04-16Clinical Trial Update: Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function
The study assessed the effects of Armolipid Plus on cholesterol levels and endothelial function in individuals with hyperlipidemia and endot…
-
FDA approval · 2008-03-26FDA Approved: FENOFIBRATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's generic fenofibrate (ANDA 076509) as an original application, establishing equivalence to the r…
-
FDA approval · 2008-03-14FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Lovastatin, finalizing changes to the generic product's approval terms and …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Metabolism and Body Shape of Healthy Children and Children With Chronic Infections
Clinical trial update on metabolism and body shape in healthy children and in children with chronic infections, including HIV infection. The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-02-29Clinical Trial Update: ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program [NA]
This is a clinical trial update for the Indo-Central Asian Cardiovascular Health Assessment and Management Program (ICA-CHAMP) sponsored by …
-
FDA approval · 2008-02-26FDA Approved: SIMVASTATIN — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's generic simvastatin as an original ANDA, enabling marketing of a generic statin for lipid-lowering indicati…
-
FDA approval · 2008-01-18FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2008-01-15FDA Approved: PRAVASTATIN SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for pravastatin sodium by Aurobindo Pharma Limited, confirming a generic pravastatin product. The drug…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating cardiovascular effects after switching to aripiprazole in overweight/obese patients with schizophrenia; th…
-
FDA approval · 2008-01-08FDA Approved: PRAVASTATIN SODIUM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic pravastatin sodium tablets under Original Application, enabling a generic statin to enter the ma…
-
CLINICAL_TRIALS trial_result · 2008-01-08Clinical Trial Update: Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes [Phase 4]
Phase 4 randomized trial comparing N-of-1 trials to standard practice to improve adherence to statins in patients with diabetes and cardiova…
-
FDA approval · 2007-12-28FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for pravastatin sodium by Quallent, updating the approval status of this generic statin.
-
FDA approval · 2007-12-28FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for pravastatin sodium submitted by Cipla USA Inc., signaling an additional regulatory approval for …
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease [Phase 3]
A Phase 3 trial comparing torcetrapib/atorvastatin to atorvastatin alone in patients with coronary heart disease has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. [Phase 3]
A Phase 3 trial comparing torcetrapib/atorvastatin versus ezetimibe/simvastatin in people with a cholesterol disorder was terminated, accord…
-
CLINICAL_TRIALS trial_result · 2007-12-03Clinical Trial Update: A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet [Phase 2, Phase 3]
This randomized, double-blind Phase 2/3 trial compared simvastatin 20 mg/day to Vytorin (ezetimibe/simvastatin 10/20) in adults with lipid p…
-
FDA approval · 2007-11-26FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZOCOR (simvastatin) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2007-11-21Clinical Trial Update: A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. [Phase 3]
Phase 3 trial comparing torcetrapib/atorvastatin versus simvastatin in adults with high cholesterol has been completed.
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone. [Phase 3]
Pfizer completed a Phase 3 trial evaluating torcetrapib in combination with atorvastatin versus atorvastatin alone in patients with hyperlip…
-
FDA approval · 2007-11-01FDA Approved: LOVASTATIN — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original ANDA for lovastatin, allowing a generic version of the statin to be marketed.
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate [Phase 3]
Phase 3 trial comparing torcetrapib/atorvastatin versus fenofibrate shows effects on HDL-C increase and non-HDL lowering in hyperlipidemia p…
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Lipid Lowering in Patients With Statin Intolerance [NA]
Clinical trial update on lipid-lowering therapy in patients with statin intolerance; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2007-10-30Clinical Trial Update: Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia [Phase 3]
Pfizer conducted a Phase 3 trial evaluating the safety and efficacy of a torcetrapib/atorvastatin combination in subjects with familial hype…
-
FDA approval · 2007-10-05FDA Approved: LOVASTATIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Lovastatin submitted by Teva Pharmaceuticals USA, Inc.